Medco just put out a study that I found very interesting since it shares data around patients opting-in to a genetic test around use of statins.
In the big picture, it showed that those got the genetic test were more adherent. Perhaps this points to a better belief in the therapy post-genetic test (similar to the placebo effect).
But, what first grabbed my eye was data on the consumers:
- 53.8% participated in the study since they believed in the utility of genetic testing
- Only 6.7% of those that declined cited privacy issues
- Only 8.8% of those that declined cited anxiety about the results
This could be very promising for something that is complex but is certainly part of the future of medicine.
No comments yet... Be the first to leave a reply!